UOC
DVAX

UBS O'Connor’s Dynavax Technologies DVAX Stock Holding History

UBS O'Connor’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-136,850
Closed -$2.63M – 431
2016
Q1 		$2.63M Buy
136,850
+116,850
+584% +$2.36M 0.03% 300
2015
Q4 		$484K Buy
+20,000
New +$501K ﹤0.01% 389
2013
Q3 		– Sell
-32,910
Closed -$362K – 460
2013
Q2 		$362K Buy
+32,910
New +$693K 0.01% 434

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GA
Glenhill Advisors New York $6.94M AUM 24.62% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

UBS O'Connor's DVAX Position: Q2 2016 in Review

UBS O'Connor sold out of Dynavax Technologies (DVAX) in Q2 2016, closing a stake of 136,850 shares — an estimated $2.63M sold.

UBS O'Connor first reported a position in DVAX in Q2 2013 and held it in 3 quarters. The position peaked at $2.63M in Q1 2016. 121 funds tracked by Wall St. Rank hold DVAX as of Q2 2016.

  • UBS O'Connor reported no remaining Dynavax Technologies position as of Q2 2016 after selling out during the quarter.
  • UBS O'Connor sold 136,850 Dynavax Technologies shares in Q2 2016, an estimated $2.63M.
  • UBS O'Connor first reported a position in Dynavax Technologies in Q2 2013 and held it in 3 quarters.
  • UBS O'Connor's Dynavax Technologies position peaked at $2.63M in Q1 2016.
  • 121 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2016.

Based on UBS O'Connor's 13F filing for Q2 2016, filed 12 Aug 2016.